METHOD FOR MODULATING STEM CELL GROWTH
    1.
    发明申请
    METHOD FOR MODULATING STEM CELL GROWTH 有权
    调节干细胞生长的方法

    公开(公告)号:US20090209643A1

    公开(公告)日:2009-08-20

    申请号:US12388048

    申请日:2009-02-18

    IPC分类号: A61K31/19 A61P43/00

    CPC分类号: C07C53/134 A61K31/5575

    摘要: In one embodiment, provided is a composition comprising a prostaglandin compound for modulating stem cell proliferation and/or differentiation in a mammalian subject. In another embodiment, the instant application is a composition comprising a prostaglandin compound for, which comprises a prostaglandin compound for modulating proliferation and/or differentiation of stem cells of a mammalian subject, in which the stem cells are contacted directly or indirectly with the composition of the invention.

    摘要翻译: 在一个实施方案中,提供了包含用于调节哺乳动物受试者的干细胞增殖和/或分化的前列腺素化合物的组合物。 在另一个实施方案中,本申请是包含前列腺素化合物的组合物,其包含用于调节哺乳动物受试者的干细胞的增殖和/或分化的前列腺素化合物,其中干细胞直接或间接与组合物 本发明。

    Method for treating mucosal disorders
    2.
    发明申请
    Method for treating mucosal disorders 审中-公开
    治疗粘膜疾病的方法

    公开(公告)号:US20060281818A1

    公开(公告)日:2006-12-14

    申请号:US11384491

    申请日:2006-03-21

    IPC分类号: A61K31/557

    CPC分类号: C07C405/00 A61K31/557

    摘要: Provided is a method for treating mucosal disorders using a specific prostaglandin compound. The prostaglandin compound induces a conformational change in the tight junction that results in recovery of mucosal barrier function. Accordingly, the prostaglandin compound used herein is useful for the treatment of mucosal disorders.

    摘要翻译: 提供了使用特定的前列腺素化合物治疗粘膜疾病的方法。 前列腺素化合物诱导紧密连接处的构象变化,导致粘膜屏障功能的恢复。 因此,本文使用的前列腺素化合物可用于治疗粘膜疾病。

    Method for modulating stem cell growth
    5.
    发明授权
    Method for modulating stem cell growth 有权
    调节干细胞生长的方法

    公开(公告)号:US08871752B2

    公开(公告)日:2014-10-28

    申请号:US12388048

    申请日:2009-02-18

    CPC分类号: C07C53/134 A61K31/5575

    摘要: In one embodiment, provided is a composition including a prostaglandin compound for modulating stem cell proliferation and/or differentiation in a mammalian subject. In another embodiment, the instant application is directed to a composition which includes a prostaglandin compound for modulating proliferation and/or differentiation of stem cells of a mammalian subject, in which the stem cells are contacted directly or indirectly with the composition of the invention.

    摘要翻译: 在一个实施方案中,提供了包含用于调节哺乳动物受试者的干细胞增殖和/或分化的前列腺素化合物的组合物。 在另一个实施方案中,本申请涉及包含用于调节哺乳动物受试者的干细胞的增殖和/或分化的前列腺素化合物的组合物,其中干细胞与本发明的组合物直接或间接接触。

    Prostaglandin cathartic
    6.
    发明授权
    Prostaglandin cathartic 失效
    前列腺素

    公开(公告)号:US5317032A

    公开(公告)日:1994-05-31

    申请号:US996495

    申请日:1992-12-30

    IPC分类号: A61K31/557

    CPC分类号: A61K31/557

    摘要: The present invention relates to cathartics comprising 15-keto-16-halogen-PGs as an essential ingredient without substantive side-effects; the catharic effect is thought mainly caused by an enteropooling effect.

    摘要翻译: 本发明涉及包含15-酮-16-卤素-PG作为必需成分而没有实质性副作用的泻药; 念aric效应主要是由于肠道毒作用引起的。

    Method for treating abdominal discomfort
    7.
    发明授权
    Method for treating abdominal discomfort 有权
    治疗腹部不适的方法

    公开(公告)号:US07795312B2

    公开(公告)日:2010-09-14

    申请号:US10745689

    申请日:2003-12-29

    IPC分类号: A61K31/5575

    摘要: A method for treating irritable bowel syndrome in a mammalian subject includes administering an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1, or a salt, ether, ester or amide thereof, to the subject. A method for treating abdominal discomfort associated with irritable bowel syndrome in a mammalian subject includes administering an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1, or a salt, ether, ester or amide thereof, to the subject.

    摘要翻译: 用于治疗哺乳动物受试者肠易激综合征的方法包括给予有效量的13,14-二氢-15-酮-16,16-二氟-18-甲基 - 前列腺素E1或13,14-二氢-15-酮 - 16,16-二氟 - 前列腺素E1或其盐,醚,酯或酰胺。 用于治疗哺乳动物受试者与肠易激综合征相关的腹部不适的方法包括给予有效量的13,14-二氢-15-酮16,16-二氟-18-甲基前列腺素E1或13,14-二氢 - 15-酮-16,16-二氟前列腺素E1或其盐,醚,酯或酰胺。

    Method for treating chronic obstructive pulmonary disease
    8.
    发明申请
    Method for treating chronic obstructive pulmonary disease 审中-公开
    治疗慢性阻塞性肺疾病的方法

    公开(公告)号:US20070203228A1

    公开(公告)日:2007-08-30

    申请号:US11711097

    申请日:2007-02-27

    IPC分类号: A61K31/558

    CPC分类号: A61K31/5575 A61K31/558

    摘要: The present invention relates to a method for treating chronic obstructive pulmonary disease in a mammalian subject, which comprises administering an effective amount of a specific bicyclic compound of formula (I): and/or a tautomer thereof to a subject in need thereof.

    摘要翻译: 本发明涉及一种用于治疗哺乳动物受试者的慢性阻塞性肺疾病的方法,其包括向有需要的受试者施用有效量的式(I)的特定双环化合物:和/或其互变异构体。

    Treatment of ocular hypertension
    9.
    发明授权
    Treatment of ocular hypertension 失效
    眼高压治疗

    公开(公告)号:US5432174A

    公开(公告)日:1995-07-11

    申请号:US162386

    申请日:1993-12-07

    CPC分类号: A61K31/557 Y10S514/913

    摘要: A method for the treatment of ocular hypertension which comprises administering, to a subject in need of such treatment,(a) a .beta.-adrenergic blocker at the enhancement phase of aqueous humor production, and(b) a prostanoic acid compound at the suppression phase of aqueous humor production, andin an amount effective in treatment of ocular hypertension.

    摘要翻译: 一种治疗眼高血压的方法,其包括向需要这种治疗的受试者施用(a)在房水生成增强阶段的β-肾上腺素能阻滞剂,和(b)抑制阶段的前列腺酸化合物 的房水产生,并且有效治疗高眼压症的量。